Concord Drugs Ltd. - Research Center
538965 CONCORD Group (X) BSE data
Results
|
Quarterly
|
Statement
|
|
More
|
|
Quarterly results in brief
(Rs crore)
|
Mar' 24 |
Dec' 23 |
Sep' 23 |
Jun' 23 |
Mar' 23 |
Sales |
14.47 |
12.62 |
7.38 |
8.79 |
11.54 |
Operating profit |
0.19 |
0.56 |
1.53 |
1.40 |
0.74 |
Interest |
0.38 |
0.43 |
0.39 |
0.39 |
0.42 |
Gross profit |
-0.19 |
0.13 |
1.15 |
1.01 |
0.32 |
EPS (Rs) |
-0.35 |
-0.24 |
0.56 |
0.52 |
0.07 |
Quarterly
results in details
|
Mar' 24 |
Dec' 23 |
Sep' 23 |
Jun' 23 |
Mar' 23 |
Other income |
- |
- |
0.01 |
- |
- |
Stock adjustment |
-0.09 |
0.01 |
-0.45 |
0.12 |
0.07 |
Raw material |
12.79 |
10.44 |
4.74 |
5.74 |
9.44 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
1.25 |
1.20 |
1.28 |
1.21 |
1.02 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
0.32 |
0.41 |
0.29 |
0.31 |
0.27 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
0.39 |
0.38 |
0.38 |
0.38 |
0.31 |
Taxation |
-0.22 |
-0.02 |
0.24 |
0.14 |
-0.05 |
Net profit / loss |
-0.35 |
-0.24 |
0.53 |
0.49 |
0.07 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
10.00 |
10.00 |
9.32 |
9.32 |
9.32 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
1.30 |
4.45 |
20.71 |
15.92 |
6.42 |
GPM (%) |
-1.30 |
- |
15.51 |
- |
2.81 |
NPM (%) |
-2.45 |
- |
7.12 |
- |
0.60 |